AU2002230217A1 - Tablets quickly disintegrated in oral cavity - Google Patents

Tablets quickly disintegrated in oral cavity

Info

Publication number
AU2002230217A1
AU2002230217A1 AU2002230217A AU2002230217A AU2002230217A1 AU 2002230217 A1 AU2002230217 A1 AU 2002230217A1 AU 2002230217 A AU2002230217 A AU 2002230217A AU 2002230217 A AU2002230217 A AU 2002230217A AU 2002230217 A1 AU2002230217 A1 AU 2002230217A1
Authority
AU
Australia
Prior art keywords
oral cavity
quickly disintegrated
tablets quickly
tablets
disintegrated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002230217A
Other versions
AU2002230217B2 (en
Inventor
Yoshiyuki Koida
Hideki Murakami
Masaaki Sugimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority claimed from PCT/JP2002/001140 external-priority patent/WO2002064119A1/en
Publication of AU2002230217A1 publication Critical patent/AU2002230217A1/en
Application granted granted Critical
Publication of AU2002230217B2 publication Critical patent/AU2002230217B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002230217A 2001-02-15 2002-02-12 Tablets quickly disintegrated in oral cavity Ceased AU2002230217B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-038343 2001-02-15
JP2001038343 2001-02-15
PCT/JP2002/001140 WO2002064119A1 (en) 2001-02-15 2002-02-12 Tablets quickly disintegrated in oral cavity

Publications (2)

Publication Number Publication Date
AU2002230217A1 true AU2002230217A1 (en) 2003-02-20
AU2002230217B2 AU2002230217B2 (en) 2005-02-17

Family

ID=18901333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230217A Ceased AU2002230217B2 (en) 2001-02-15 2002-02-12 Tablets quickly disintegrated in oral cavity

Country Status (12)

Country Link
US (1) US7927623B2 (en)
EP (1) EP1366760B1 (en)
JP (1) JP4179784B2 (en)
KR (1) KR100750554B1 (en)
CN (1) CN100372536C (en)
AT (1) ATE472319T1 (en)
AU (1) AU2002230217B2 (en)
CA (1) CA2437754C (en)
DE (1) DE60236850D1 (en)
MX (1) MXPA03007283A (en)
NZ (1) NZ527585A (en)
WO (1) WO2002064119A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03010119A (en) * 2001-05-09 2005-03-07 Bayer Healthcare Ag Novel use of 2-phenyl-substituted imidazotriazinones.
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EP1552851A1 (en) * 2002-06-10 2005-07-13 Dainippon Pharmaceutical Co., Ltd. Rapidly disintegrating tablet and process for producing the same
DE10232113A1 (en) * 2002-07-16 2004-01-29 Bayer Ag Medicinal products containing vardenafil hydrochloride trihydrate
EA009985B1 (en) 2003-03-10 2008-04-28 Никомед Гмбх Novel process for the preparation of roflumilast
GB0317663D0 (en) * 2003-07-29 2003-09-03 Astrazeneca Ab Pharmaceutical composition
CN1913876B (en) * 2003-12-09 2013-06-26 大日本住友制药株式会社 Drug-containing grains and solid preparation containing the grains
KR20140104986A (en) * 2004-02-17 2014-08-29 트랜스셉트 파마슈티칼스, 인코포레이티드 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
DE102004023069A1 (en) * 2004-05-11 2005-12-08 Bayer Healthcare Ag New dosage forms of the PDE 5 inhibitor vardenafil
DE102005001989A1 (en) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenous formulations of PDE inhibitors
DE102005009240A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with improved pharmacokinetic properties
DE102005009241A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with controlled bioavailability
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
KR20080031208A (en) * 2005-05-25 2008-04-08 트랜스셉트 파마슈티칼스, 인코포레이티드 Solid compositions and methods for treating middle-of-the night insomnia
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
KR101011278B1 (en) * 2005-07-22 2011-01-28 미쓰비시 타나베 파마 코퍼레이션 Rapidly disintegratable oral tablet
BRPI0616633A2 (en) * 2005-09-29 2011-06-28 Bayer Healthcare Ag pde inhibitors and combinations thereof for the treatment of urological disorders
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2007091856A1 (en) * 2006-02-10 2007-08-16 Lg Household & Health Care Ltd. In-situ melting and gelling tablet composition for oral care
US20080069891A1 (en) * 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
CA2673458A1 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
WO2008081891A1 (en) * 2006-12-28 2008-07-10 Takeda Pharmaceutical Company Limited Orally disintegrating solid preparation
CN101711153A (en) * 2007-06-13 2010-05-19 拜耳先灵制药股份公司 The PDE inhibitor that is used for the treatment of acoustic trauma
JP5557832B2 (en) * 2008-03-18 2014-07-23 メルク・シャープ・アンド・ドーム・コーポレーション Substituted 4-hydroxypyridine-5-carboxamide
JP5594285B2 (en) * 2009-03-16 2014-09-24 ニプロ株式会社 Orally disintegrating tablets
CN102387833B (en) * 2009-03-20 2016-01-13 因卡伯实验室有限责任公司 Solid drugs administration device
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
MX2013000284A (en) 2010-07-09 2013-03-18 Teijin Pharma Ltd Orally disintegrating tablet.
US9011912B2 (en) 2010-10-07 2015-04-21 Abon Pharmaceuticals, Llc Extended-release oral dosage forms for poorly soluble amine drugs
JP6245786B2 (en) * 2011-10-17 2017-12-13 大同化成工業株式会社 Pharmaceutical binding agent and preparation using the binding agent
HRP20211606T1 (en) 2012-02-21 2022-01-21 Towa Pharmaceutical Europe, S.L. Oral pharmaceutical compositions of dabigatran etexilate
JP5292520B1 (en) * 2013-02-13 2013-09-18 アピ株式会社 Royal jelly-containing tablet and method for producing the same
ES2843576T3 (en) * 2016-02-05 2021-07-19 Tiense Suikerraffinaderij Nv Pearl sugar; pearl sugar preparation procedure

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4820103B1 (en) 1968-05-06 1973-06-19
US5073048A (en) * 1987-07-06 1991-12-17 Asahi Kogaku Kogyo K.K. Optical fiber bundle
DE3827214A1 (en) * 1988-08-11 1990-02-15 Roehm Gmbh RETARDED MEDICAMENT AND METHOD FOR THE PRODUCTION THEREOF
JP3069458B2 (en) * 1992-01-29 2000-07-24 武田薬品工業株式会社 Orally disintegrating tablet and production method thereof
US5254355A (en) * 1992-05-29 1993-10-19 Kraft General Foods, Inc. Process for beverage tablets and products therefrom
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9514465D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
JP3187657B2 (en) 1994-07-08 2001-07-11 株式会社三共製作所 Tablet manufacturing method and device
JP3067125B2 (en) 1994-11-22 2000-07-17 田辺製薬株式会社 Easy-to-take nucleated tablet-type preparation
GB9423911D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
DE19501481A1 (en) 1995-01-19 1996-07-25 Bayer Ag 2,8-disubstituted quinazolinones
DE19501480A1 (en) * 1995-01-19 1996-07-25 Bayer Ag 9-substituted 2- (2-n-alkoxyphenyl) -purin-6-one
DE19501482A1 (en) * 1995-01-19 1996-07-25 Bayer Ag 2,9-disubstituted purine-6-ones
EP0820441B1 (en) * 1995-04-10 2002-06-26 Fujisawa Pharmaceutical Co., Ltd. INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
CA2221351A1 (en) * 1995-05-18 1996-11-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Cyclohexyl dihydrobenzofuranes
CA2221357A1 (en) * 1995-05-18 1996-11-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenyl dihydrobenzofuranes
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514464D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
JPH0948726A (en) * 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd Rapidly disintegrating preparation in mouth cavity and its production
DE19541264A1 (en) * 1995-11-06 1997-05-07 Bayer Ag Purin-6-one derivatives
US6191138B1 (en) * 1996-01-31 2001-02-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
US6087311A (en) * 1996-12-06 2000-07-11 The Proctor & Gamble Company Coated detergent tablet
AU6230098A (en) 1997-02-27 1998-09-18 Tanabe Seiyaku Co., Ltd. Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors
JPH10298062A (en) 1997-04-24 1998-11-10 Pfizer Pharmaceut Co Ltd Rapidly dissolving type tablet in oral cavity
JP3296412B2 (en) 1997-04-25 2002-07-02 田辺製薬株式会社 Molded preparation and its manufacturing method
TW580397B (en) 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
JP4939680B2 (en) * 1997-05-27 2012-05-30 武田薬品工業株式会社 Solid preparation
JP3591801B2 (en) * 1997-06-19 2004-11-24 田辺製薬株式会社 Manufacturing method of oral disintegrating preparation
WO1999004758A1 (en) 1997-07-25 1999-02-04 Elan Corporation Plc A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
DK1736144T3 (en) * 1998-05-18 2015-12-07 Takeda Pharmaceutical Orally disintegrating tablets.
JP2000095759A (en) 1998-07-21 2000-04-04 Takeda Chem Ind Ltd Tricyclic compound, its production, and phosphodiesterase inhibitor
ATE481090T1 (en) * 1998-07-28 2010-10-15 Takeda Pharmaceutical EASILY DISSOLVING SOLID PREPARATION
JP2000072751A (en) 1998-08-26 2000-03-07 Tanabe Seiyaku Co Ltd Isoquinolinone derivative
JP2000072675A (en) 1998-08-26 2000-03-07 Tanabe Seiyaku Co Ltd Pharmaceutical composition
UA67802C2 (en) 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. CONTROLLED-RELEASE FORMULATIONS FOR ORAL ADMINISTRATION CONTAINING cGMP PDE-5 INHIBITOR (VARIANTS), METHOD FOR ITS PREPARATION AND METHOD FOR TREATING ERECTILE DYSFUNCTION
GB9823103D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
GB9823101D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
JP2000128774A (en) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd Production of globular, fine grain including medicine
AU3574500A (en) * 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
BRPI0014526C1 (en) 1999-09-16 2021-05-25 Mitsubishi Tanabe Pharma Corp cyclic compounds of six elements containing aromatic nitrogen, pharmaceutical composition and use thereof

Similar Documents

Publication Publication Date Title
AU2002230217A1 (en) Tablets quickly disintegrated in oral cavity
AU2002255321A1 (en) Tablets quickly disintegrating in the oral cavity and process for producing the same
AU2002255321A2 (en) Tablets quickly disintegrating in the oral cavity and process for producing the same
EP1674083A4 (en) Tablet quickly disintegrating in oral cavity
EP1120120A4 (en) Tablets immediately disintegrating in the oral cavity
AU6089200A (en) Rapid immediate release oral dosage form
AU2002244154A1 (en) Divalproex sodium tablets
AU2001268743A1 (en) Oral care compositions comprising chlorite and methods
AU2001248751A1 (en) Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity
AU2001294250A1 (en) Medicinal compositions quickly disintegrating in the oral cavity and process forproducing the same
AU2003238670A1 (en) Fast disintegrating oral dosage forms
AU2002221096A1 (en) Medicinal compositions improved in solublity in water
AU2001259693A1 (en) Oral devices
AU2002214324A1 (en) Medicinal compositions
GB0025888D0 (en) Jaw crusher unit
AU2001290239A1 (en) Medicinal composition
AU2002343025A1 (en) Improvements in footwear
AU2003284942A1 (en) Oral extended release tablets and methods of making and using the same
AU2003218261A1 (en) Improvements in pharmaceutical discovery and development
AU2001280830A1 (en) Paroxetine tablets and capsules
AU2001241187A1 (en) Sustained release oral preparations
AU5428800A (en) Tablets quickly disintegrating in mouth
AU2003211128A1 (en) Transgenic production in saliva
AU2003206471A1 (en) Dental wedge
AU2001278487A1 (en) Oral composition